Business
Defiance has launched the world's second psychedelics-focused ETF as investing in psychedelic therapy and treatment accelerates....
In today's episode of "This Week in Psychedelic Stocks", we'll see some news on MindMed (MMED / MMEDF/MMQ), Compass Pathways...
This week in psychedelic business news: two companies enter the Canadian Stock Exchange, AI comes to psychedelic treatment, and psilocybin...
Biotech company Atai Life Sciences has earned a $2 billion valuation for its work in developing psychedelic treatments for mental...
Hello psychedelic investors! Today’s episode will be a little different. We will discuss the recent media coverage of psychedelic stocks...
Hello Psychedelic Investors! In this new segment entitled "This Week in Psychedelic Stocks", we'll see some news on MindMed (MMED...
This week in psychedelic business news, Field Trip upsizes its bought deal, psilocybin truffles head to Brazil, another company goes...
NYU will open a $10 million psychedelic research center to further its work in using psychedelic substances to treat mental...
Hello Psychedelic Investors! As I mentioned in the previous episode of the Psychedelic Investor, last week I had my first...
This week in psychedelic business news: MindMed acquires a digital health company, Mindest Pharma goes public, new MDMA treatment for...